143 related articles for article (PubMed ID: 36695863)
1. The role of oncology pharmacists and comprehensive medication reconciliation in informing treatment plans for older adults with cancer and downstream outcomes.
Whitman A; Fitch E; Nightingale G
Curr Opin Support Palliat Care; 2023 Mar; 17(1):3-7. PubMed ID: 36695863
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive pharmacological geriatric assessment compared to usual care in an older adult with cancer in the absence of polypharmacy.
Walsh DJ; Sahm LJ; O'Driscoll M; Tabb E; Hannan M; Horgan AM
J Oncol Pharm Pract; 2023 Oct; 29(7):1776-1780. PubMed ID: 37332111
[TBL] [Abstract][Full Text] [Related]
3. Decreasing polypharmacy in older adults with cancer: A pilot cluster-randomized trial protocol.
Ramsdale E; Mohamed M; Holmes HM; Zubkoff L; Bauer J; Norton SA; Mohile S
J Geriatr Oncol; 2024 Mar; 15(2):101687. PubMed ID: 38302299
[TBL] [Abstract][Full Text] [Related]
4. A Pharmacist-Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV-Positive Patients.
McNicholl IR; Gandhi M; Hare CB; Greene M; Pierluissi E
Pharmacotherapy; 2017 Dec; 37(12):1498-1506. PubMed ID: 29023938
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.
Nightingale G; Hajjar E; Swartz K; Andrel-Sendecki J; Chapman A
J Clin Oncol; 2015 May; 33(13):1453-9. PubMed ID: 25800766
[TBL] [Abstract][Full Text] [Related]
6. A pharmacist-led medication assessment used to determine a more precise estimation of the prevalence of complementary and alternative medication (CAM) use among ambulatory senior adults with cancer.
Nightingale G; Hajjar E; Guo K; Komura S; Urnoski E; Sendecki J; Swartz K; Chapman A
J Geriatr Oncol; 2015 Sep; 6(5):411-7. PubMed ID: 26277113
[TBL] [Abstract][Full Text] [Related]
7. A systematic scoping review of interventions to optimise medication prescribing and adherence in older adults with cancer.
Murphy M; Bennett K; Ryan S; Hughes CM; Lavan AH; Cadogan CA
Res Social Adm Pharm; 2022 Mar; 18(3):2392-2402. PubMed ID: 33903064
[TBL] [Abstract][Full Text] [Related]
8. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
9. Impact of Computer-Based and Pharmacist-Assisted Medication Review Initiated in the Emergency Department.
Liu YL; Chu LL; Su HC; Tsai KT; Kao PH; Chen JF; Hsieh HC; Lin HJ; Hsu CC; Huang CC
J Am Geriatr Soc; 2019 Nov; 67(11):2298-2304. PubMed ID: 31335969
[TBL] [Abstract][Full Text] [Related]
10. Potentially inappropriate prescribing in older adults with advanced chronic kidney disease.
Molnar AO; Bota S; Jeyakumar N; McArthur E; Battistella M; Garg AX; Sood MM; Brimble KS
PLoS One; 2020; 15(8):e0237868. PubMed ID: 32818951
[TBL] [Abstract][Full Text] [Related]
11. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial.
Martin P; Tamblyn R; Benedetti A; Ahmed S; Tannenbaum C
JAMA; 2018 Nov; 320(18):1889-1898. PubMed ID: 30422193
[TBL] [Abstract][Full Text] [Related]
12. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
[TBL] [Abstract][Full Text] [Related]
13. A survey on patients medication reconciliation process in an oncological hospital.
Gorreja F; Damuzzo V; Gallo U; Russi A; Lo Re F; Ciampalini S; Guidotti L; Serena M; Palozzo AC
Recenti Prog Med; 2017 Mar; 108(3):141-148. PubMed ID: 28398408
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy in chronic kidney disease: Health outcomes & pharmacy-based strategies to mitigate inappropriate polypharmacy.
Onor IO; Ahmed F; Nguyen AN; Ezebuenyi MC; Obi CU; Schafer AK; Borghol A; Aguilar E; Okogbaa JI; Reisin E
Am J Med Sci; 2024 Jan; 367(1):4-13. PubMed ID: 37832917
[TBL] [Abstract][Full Text] [Related]
15. Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist.
Deliens C; Deliens G; Filleul O; Pepersack T; Awada A; Piccart M; Praet JP; Lago LD
J Geriatr Oncol; 2016 Nov; 7(6):463-470. PubMed ID: 27238734
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of drug-related problems identified in pharmacy-based medication reviews.
Sell R; Schaefer M
Int J Clin Pharm; 2020 Apr; 42(2):588-597. PubMed ID: 32026355
[TBL] [Abstract][Full Text] [Related]
17. Combined Use of the Rationalization of Home Medication by an Adjusted STOPP in Older Patients (RASP) List and a Pharmacist-Led Medication Review in Very Old Inpatients: Impact on Quality of Prescribing and Clinical Outcome.
Van der Linden L; Decoutere L; Walgraeve K; Milisen K; Flamaing J; Spriet I; Tournoy J
Drugs Aging; 2017 Feb; 34(2):123-133. PubMed ID: 27915457
[TBL] [Abstract][Full Text] [Related]
18. Polypharmacy in the Emergency Department.
Nguyen KH; Tolia V; Hart LA
Clin Geriatr Med; 2022 Nov; 38(4):727-732. PubMed ID: 36210088
[TBL] [Abstract][Full Text] [Related]
19. Electronic surveillance and pharmacist intervention for vulnerable older inpatients on high-risk medication regimens.
Peterson JF; Kripalani S; Danciu I; Harrell D; Marvanova M; Mixon AS; Rodriguez C; Powers JS
J Am Geriatr Soc; 2014 Nov; 62(11):2148-52. PubMed ID: 25366414
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.
Whitman AM; DeGregory KA; Morris AL; Ramsdale EE
Oncologist; 2016 Jun; 21(6):723-30. PubMed ID: 27151653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
